Results 161 to 170 of about 22,319 (215)
Dupilumab in chronic obstructive pulmonary disease: a pooled analysis of emergency department visits, hospital admissions, and systemic corticosteroid use. [PDF]
Am J Respir Crit Care MedBhatt SP, Martinez FJ, Satia I, Anzueto A, Bourbeau J, Papi A, Korn S, Deslée G, Xia C, Heble J, Soliman M, Bafadhel M. +11 moreeuropepmc +1 more sourceA data-driven framework reconstructs the molecular continuum of human MASLD progression. [PDF]
Nat MetabKamzolas I, Koutsandreas T, Barker CG, Vathrakokoili Pournara A, Weston H, Fujiwara N, Hoshida Y, Anstee QM, Vacca M, Papatheodorou I, Vidal-Puig A, Petsalaki E. +11 moreeuropepmc +1 more sourceThe Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD. [PDF]
JHEP RepTiniakos DG, Bedossa P, Arola J, Davies S, Gouw ASH, Guido M, Lackner C, Schirmacher P, Terracciano L, Blain A, Wonders K, Anstee QM, Ratziu V, Paradis V. +13 moreeuropepmc +1 more sourceAirway wall thickness and PRISm are associated with cognitive impairment in individuals with cigarette smoking exposure. [PDF]
Respir ResHoth KF, Linkenmeyer C, Kinney GL, Newell JD, Regan EA, Make B, Pratte KA, Comellas AP, Hoffman EA, Fortis S, Fiedorowicz JG, DeMeo DL, Yohannes AM, Iyer AS, Foreman MG, Bhatt SP, Kunisaki KM, Lutz SM, Silverman EK, Crapo JD, Austin E. +20 moreeuropepmc +1 more sourceChronic obstructive pulmonary disease and risk of incident cardiovascular disease, chronic kidney disease, and death: a systematic review and meta-analysis. [PDF]
EClinicalMedicineJoseph T, Gao C, Nadarajah R, Al-Lehebi R, Alves L, Berg DD, Couper A, Datta I, Eleyan L, Haris M, Hawkins N, Hurst JR, Jenkins CR, Kaplan A, Kocks JWH, Kostikas K, Lam CS, Laperre T, Martinez F, Mircescu A, Montero Arias MF, Nadeem U, Nguyen L, Wignall K, Pullen R, Raveendra K, Rhee CK, Sattar N, Stolz D, Sun Y, Tse G, Winders T, Price DB, Bhutani M, Wu J, Gale CP. +35 moreeuropepmc +1 more sourceNeeds assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis. [PDF]
Commun Med (Lond)Sena E, Tacke F, Anstee QM, Di Prospero N, Skalshøi-Kjær M, Muñoz-Martínez S, Rivera-Esteban J, Jiménez-Masip A, Bañales JM, Martínez-Gómez M, Koenig F, Genescà J, Ratziu V, Pericàs JM. +13 moreeuropepmc +1 more sourceExploration of the genetic architecture of ANCA-associated vasculitis. [PDF]
EBioMedicineByun J, Shaw VR, Zhu C, Han Y, Sun R, Zhang Z, Xiao X, Pinder BD, Zhang J, Tadesse Y, Riley TR, Chung S, Cuthbertson D, Dellaripa PF, Dua AB, Gewurz-Singer O, Forbess LJ, Langford CA, Khalidi N, Koening C, Mahr AD, McAlear C, Monach PA, Moreland L, Pagnoux C, Seo EP, Specks U, Spiera RF, Sreih A, Springer JM, St Clair EW, Warrington KJ, Ytterberg SR, Edberg JC, Grayson PC, Jayne D, Smith R, Walsh M, Merkel PA, Siminovitch KA, Amos CI, Vasculitis Clinical Research Consortium. +41 moreeuropepmc +1 more sourceProspective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study. [PDF]
Nat MedPavlides M, Vali Y, Mózes FE, Wonders K, Akhtar S, Hockings PD, Shumbayawonda E, Pepin K, Fernandez-Lizaranzu I, Leeming DJ, Cobbold JF, Allison MED, Aithal GP, Romero-Gomez M, Aller R, Pericàs JM, Boursier J, Petta S, Schattenberg JM, Ekstedt M, Berzigotti A, Yki-Järvinen H, Martic M, Tuthill T, Brass CA, Kalutkiewicz M, Banerjee R, Ehman RL, Schneider MJ, Tiniakos D, Karsdal M, Magnanensi J, Fournier-Poizat C, Ratziu V, Yunis C, Bugianesi E, Harrison SA, LITMUS Consortium Investigators, Bossuyt PM, Anstee QM. +39 moreeuropepmc +1 more source
